trbp antikoerper, trbp1 antikoerper, trbp2 antikoerper, MGC97783 antikoerper, TARBP2 antikoerper, LOQS antikoerper, TRBP antikoerper, TRBP1 antikoerper, TRBP2 antikoerper, fj51e12 antikoerper, wu:fj51e12 antikoerper, zgc:63778 antikoerper, Prbp antikoerper, TAR (HIV-1) RNA binding protein 2 antikoerper, TARBP2, RISC loading complex RNA binding subunit antikoerper, TAR (HIV-1) RNA binding protein 2 L homeolog antikoerper, TAR (HIV) RNA binding protein 2 antikoerper, tarbp2 antikoerper, TARBP2 antikoerper, tarbp2.L antikoerper, Tarbp2 antikoerper
Hintergrund
HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene binds between the bulge and the loop of the HIV-1 TAR RNA regulatory element and activates HIV-1 gene expression in synergy with the viral Tat protein. Alternative splicing results in multiple transcript variants encoding different isoforms. This gene also has a pseudogene. [provided by RefSeq, Jul 2008],LOQS, TRBP, TRBP1, TRBP2,Epigenetics & Nuclear Signaling,Nuclear Receptor Signaling,TARBP2